LEUKAEMIA
Clinical trials for LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new LEUKAEMIA trials appear
Sign up with your email to follow new studies for LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called EBNK-001, which uses donor natural killer (NK) cells to fight advanced solid tumors. About 83 adults with cancers like lung, breast, or colorectal cancer that have not responded to standard treatments will receive the NK cells along with ch…
Matched conditions: LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
AI chatbots could boost clinical trial enrollment in blood cancer patients
Knowledge-focused Recruiting nowThis study tests whether an AI-powered chatbot can help people with blood cancers (like leukemia, lymphoma, or multiple myeloma) better understand clinical trials and feel more willing to join one. About 196 participants will receive either standard education or AI-assisted educa…
Matched conditions: LEUKAEMIA
Phase: NA • Sponsor: Zhongnan Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Florida cancer study aims to speed up personalized treatment plans
Knowledge-focused Recruiting nowThis study is testing whether a new lab platform can quickly suggest personalized cancer treatments for 210 patients in Florida whose cancer has come back or not responded to standard therapy. The platform combines drug sensitivity testing and genetic profiling to recommend optio…
Matched conditions: LEUKAEMIA
Phase: NA • Sponsor: First Ascent Biomedical Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC